Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Azimuth Capital Investment Management LLC

Azimuth Capital Investment Management LLC reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 50.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 35,649 shares of the biotechnology company’s stock after selling 36,575 shares during the quarter. Azimuth Capital Investment Management LLC’s holdings in Axon Enterprise were worth $21,187,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Quantinno Capital Management LP raised its position in shares of Axon Enterprise by 32.3% in the third quarter. Quantinno Capital Management LP now owns 7,846 shares of the biotechnology company’s stock valued at $3,135,000 after buying an additional 1,914 shares during the last quarter. Stifel Financial Corp raised its holdings in Axon Enterprise by 32.8% in the 3rd quarter. Stifel Financial Corp now owns 23,945 shares of the biotechnology company’s stock valued at $9,568,000 after acquiring an additional 5,914 shares during the last quarter. Kovitz Investment Group Partners LLC purchased a new position in Axon Enterprise in the 3rd quarter worth approximately $328,000. National Bank of Canada FI boosted its holdings in shares of Axon Enterprise by 34.0% during the 3rd quarter. National Bank of Canada FI now owns 35,100 shares of the biotechnology company’s stock worth $14,026,000 after purchasing an additional 8,900 shares during the last quarter. Finally, Orion Portfolio Solutions LLC boosted its holdings in shares of Axon Enterprise by 1.3% during the 3rd quarter. Orion Portfolio Solutions LLC now owns 3,134 shares of the biotechnology company’s stock worth $1,252,000 after purchasing an additional 39 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Up 0.3 %

Shares of NASDAQ AXON opened at $504.03 on Wednesday. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The business’s 50 day moving average is $574.82 and its two-hundred day moving average is $557.07. The firm has a market cap of $38.62 billion, a price-to-earnings ratio of 130.24, a PEG ratio of 5.17 and a beta of 1.13. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Analyst Ratings Changes

A number of equities analysts recently commented on AXON shares. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Needham & Company LLC reissued a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. TD Cowen began coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. Finally, JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $604.67.

Insider Buying and Selling

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.